Indo Us Biotech Limited (NSE: INDOUS), ISIN INE250Z01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDOUS last traded at ₹84.00 (+0.78%), with a 52-week range of ₹81.51 to ₹182.80 (as of 29 Jul 2026).
Shareholding as of Mar 2026: promoters 68.29%, FIIs 0.18%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 11/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.